Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
Noelle V. Frey(Hospital of the University of Pennsylvania), David L. Porter(Chapman University), Pamela A. Shaw(University of Pennsylvania), James K. Mangan(UC San Diego Health System), Bruce L. Levine(University of Pennsylvania), Alexander E. Perl(University of Pennsylvania), Saar Gill(Parker Institute for Cancer Immunotherapy), Alison W. Loren(University of Pennsylvania), Simon F. Lacey(University of Pennsylvania), Shannon L. Maude(Children's Hospital of Philadelphia), Joan Gilmore(University of Pennsylvania), Stephan A. Grupp(Children's Hospital of Philadelphia), Edward Pequignot(University of Pennsylvania), Nirav N. Shah(Medical College of Wisconsin), Elizabeth O. Hexner(University of Pennsylvania), Carl H. June(University of Pennsylvania), Jos Melenhorst(University of Pennsylvania), Selina M. Luger(University of Pennsylvania)
Cited by 274
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k